• Contact Us
GI Dynamics
  • Home
  • EndoBarrier
    • About EndoBarrier
    • Clinical Trials
  • Company
    • Who We Are
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Press
    • Announcements
    • Press Releases
    • GID in the Media
    • Publications & Abstracts
Select Page

BioWorld

by Janell Shields | Jan 28, 2020 | GID In the Media, Publication Media

GI Dynamics enrolls first patient in pivotal EndoBarrier trial

Michigan Health Lab

by Janell Shields | Jul 8, 2019 | GID In the Media, Publication Media

Minimally-Invasive, Innovative Therapy Used for Treating Type 2 Diabetes and Obesity U-M expert discusses an upcoming clinical trial involving a new non-invasive, endoscopic weight-loss procedure called the EndoBarrier®.

Medical Device and Diagnostic Industry (MD+DI)

by Janell Shields | Mar 20, 2019 | GID In the Media, Publication Media

GI Dynamics continues to turn its story around with UK study.

Everyday Health

by Janell Shields | Feb 13, 2019 | GID In the Media, Publication Media

The EndoBarrier Device for Type 2 Diabetes: What You Need to Know

Diabetes.co.uk

by Janell Shields | Jan 15, 2019 | GID In the Media, Publication Media

EndoBarrier – What is the EndoBarrier?

Boston Globe

by Janell Shields | Oct 8, 2018 | GID In the Media, Publication Media

New Devices to Combat Obesity, from Three Boston-Area Firms
Page 1 of 3123»

Press Releases

  • GI Dynamics Announces First Patient Enrolled in the I-STEP Clinical Study of EndoBarrier in India

    February 13, 2023
  • GI Dynamics Announces the Presentation of Updated Data Sets at the 2022 Meeting of the American Diabetes Association

    July 14, 2022
    Data demonstrate favorable safety and efficacy profile for the duodenal …
  • GI Dynamics Announces Final Data from the ENDO Trial, a Multicenter Study Demonstrating the Potential Use of EndoBarrier to Treat Type II Diabetes and Obesity.

    June 15, 2022
    Initial results show the duodenal jejunal bypass liner (DJBL) technology …

Videos

  • How EndoBarrier Works

    How EndoBarrier Works

    June 24, 2019
    EndoBarrier: Non-surgical Treatment for Patients with Type 2 Diabetes and …
  • Maintenance of Efficacy after EndoBarrier

    Maintenance of Efficacy after EndoBarrier

    July 28, 2017
    UK First NHS EndoBarrier Service – Dr. Bob Ryder June …
  • BBC News Item

    BBC News Item

    January 4, 2017
    EndoBarrier treatment for diabetes & obesity following 1 year results …
  • Home
  • EndoBarrier
    • About EndoBarrier
    • Clinical Trials
  • Company
    • Who We Are
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Press
    • Announcements
    • Press Releases
    • GID in the Media
    • Publications & Abstracts
  1. Copyright Info
  2. Terms of Use
  3. Privacy Policy
  4. Patents
  5. Careers

 

CAUTION: EndoBarrier is not approved for sale in the European Union or in the United States and is limited by Federal (US) Law to investigational use only. 
 


GI Dynamics
320 Congress Street 
3rd Floor
Boston, MA 02210

  • Home
  • EndoBarrier
  • Company
  • Press

Designed by Elegant Themes | Powered by WordPress

This website uses cookies to provide you with the best browsing experience.

Find out more or adjust your settings.

GI Dynamics
Powered by GDPR plugin
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.